1 – 50 of 78
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Editorial : Celebration of DNA Day
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
From master’s thesis to research publication : a mixed-methods study of medical student publishing and experiences with the publishing process
(
- Contribution to journal › Article
-
Mark
Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells
(
- Contribution to journal › Article
-
Mark
Interleukin-1 receptor accessory protein (IL-1RAP) : A magic bullet candidate for immunotherapy of human malignancies
(
- Contribution to journal › Scientific review
- 2023
-
Mark
SPATA2 restricts OTULIN-dependent LUBAC activity independently of CYLD
(
- Contribution to journal › Article
-
Mark
PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia
(
- Contribution to journal › Article
-
Mark
Tetraploidization Increases the Motility and Invasiveness of Cancer Cells
(
- Contribution to journal › Article
- 2022
-
Mark
The roles of interleukin-1 receptor accessory protein in certain inflammatory conditions
(
- Contribution to journal › Scientific review
-
Mark
Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma
(
- Contribution to journal › Article
-
Mark
Engineering human mini-bones for the standardized modeling of healthy hematopoiesis, leukemia, and solid tumor metastasis
(
- Contribution to journal › Article
- 2021
-
Mark
Novel Cyclophilin Inhibitor Decreases Cell Proliferation and Tumor Growth in Models of Hepatocellular Carcinoma
(
- Contribution to journal › Article
- 2020
-
Mark
CYLD, a mechanosensitive deubiquitinase, regulates TGFβ signaling in load-induced bone formation
(
- Contribution to journal › Article
-
Mark
Discovery of epi-enprioline as a novel drug for the treatment of vincristine resistant neuroblastoma
(
- Contribution to journal › Article
-
Mark
Gene expression signature of acquired chemoresistance in neuroblastoma cells
(
- Contribution to journal › Article
-
Mark
Deletion of nemo-like kinase in T cells reduces single-positive CD8+thymocyte population
(
- Contribution to journal › Article
-
Mark
Preferential Killing of Tetraploid Colon Cancer Cells by Targeting the Mitotic Kinase PLK1
(
- Contribution to journal › Article
-
Mark
Inhibition of mitotic kinase Mps1 promotes cell death in neuroblastoma
(
- Contribution to journal › Article
-
Mark
High expression of CD34 and α6-integrin contributes to the cancer-initiating cell behaviour in ultraviolet-induced mouse skin squamous cell carcinoma
(
- Contribution to journal › Article
-
Mark
Nemo-like kinase in development and diseases : Insights from mouse studies
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Decreased expression of nemo-like kinase in melanoma is correlated with increased vascularity and metastasis
(
- Contribution to journal › Article
-
Mark
Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis
(
- Contribution to journal › Article
-
Mark
Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis
(
- Contribution to journal › Article
- 2018
-
Mark
BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma article
(
- Contribution to journal › Article
-
Mark
Reversine inhibits Colon Carcinoma Cell Migration by Targeting JNK1
(
- Contribution to journal › Article
-
Mark
The Molecular Basis for Inhibition of Stemlike Cancer Cells by Salinomycin
(
- Contribution to journal › Article
- 2017
-
Mark
UVB radiation represses CYLD expression in melanocytes
(
- Contribution to journal › Article
-
Mark
NLK-mediated phosphorylation of HDAC1 negatively regulates Wnt signaling
(
- Contribution to journal › Article
- 2016
-
Mark
Cylindromatosis-A Protective Molecule against Liver Diseases.
(
- Contribution to journal › Scientific review
-
Mark
Putative role of SUMOylation in controlling the activity of deubiquitinating enzymes in cancer.
(
- Contribution to journal › Scientific review
-
Mark
Nemo-like kinase regulates the expression of vascular endothelial growth factor (VEGF) in alveolar epithelial cells
(
- Contribution to journal › Article
-
Mark
CYLD and SUMO in neuroblastoma therapy
(
- Contribution to journal › Article
- 2015
-
Mark
Early diagnostic value of Bcl-3 localization in colorectal cancer.
(
- Contribution to journal › Article
-
Mark
Multifaceted role of the ubiquitin ligase Itch in immune regulation.
(
- Contribution to journal › Scientific review
-
Mark
The E3 ubiquitin ligase Itch inhibits p38α signaling and skin inflammation through the ubiquitylation of Tab1.
(
- Contribution to journal › Article
-
Mark
Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells.
(
- Contribution to journal › Article
- 2014
-
Mark
Association of nuclear-localized nemo-like kinase with heat-shock protein 27 inhibits apoptosis in human breast cancer cells.
(
- Contribution to journal › Article
-
Mark
CYLD regulates HGF expression in hepatic stellate cells via interaction with HDAC7.
(
- Contribution to journal › Article
-
Mark
CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.
(
- Contribution to journal › Article
-
Mark
Deubiquitination of γ-tubulin by BAP1 prevents chromosome instability in breast cancer cells.
(
- Contribution to journal › Article
- 2013
-
Mark
PKC theta/beta and CYLD Are Antagonistic Partners in the NF kappa B and NFAT Transactivation Pathways in Primary Mouse CD3(+) T Lymphocytes
(
- Contribution to journal › Article
-
Mark
CYLD Enhances Severe Listeriosis by Impairing IL-6/STAT3-Dependent Fibrin Production
(
- Contribution to journal › Article
-
Mark
Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer.
(
- Contribution to journal › Article
- 2012
-
Mark
A20 and CYLD Do Not Share Significant Overlapping Functions during B Cell Development and Activation
(
- Contribution to journal › Article
- 2011
-
Mark
The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation
(
- Contribution to journal › Article
-
Mark
Caspase 8 inhibits programmed necrosis by processing CYLD
(
- Contribution to journal › Article
-
Mark
Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer.
(
- Contribution to journal › Article
-
Mark
GLI1-dependent transcriptional repression of CYLD in basal cell carcinoma
(
- Contribution to journal › Article
-
Mark
CYLD: a deubiquitination enzyme with multiple roles in cancer.
(
- Contribution to journal › Article
-
Mark
Serum Response Factor Controls CYLD Expression via MAPK Signaling Pathway.
(
- Contribution to journal › Article
- 2010
-
Mark
CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin
(
- Contribution to journal › Article